Wealth Enhancement Advisory Services’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$472K Buy
7,591
+333
+5% +$15.1K ﹤0.01% 2876
2026
Q2
$207K Buy
+7,258
New +$158K ﹤0.01% 3556
2025
Q1
– Sell
-9,813
Closed -$210K – 3011
2024
Q4
$210K Buy
+9,813
New +$239K ﹤0.01% 2660

Other funds holding CDNA

Wealth Enhancement Advisory Services's CDNA Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its CareDx (CDNA) stake by 4.6% in Q3 2026, buying an estimated $15.1K and bringing the position to 7,591 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.

Wealth Enhancement Advisory Services first reported a position in CDNA in Q4 2024 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Wealth Enhancement Advisory Services held 7,591 shares of CareDx worth $472K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 333 CareDx shares in Q3 2026, an estimated $15.1K.
  • CareDx made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #2876 holding.
  • Wealth Enhancement Advisory Services first reported a position in CareDx in Q4 2024 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.